← Leaderboards
Richard H. Ebright
Rutgers The St Univ Of Nj New Brunswick
$32,377,168
Attributed
$32,377,168
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,377,168 · 11
By mechanism
R01$20,652,564 · 5
U19$6,711,020 · 4
R37$5,013,584 · 1
P20$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Anti-Bacterial Agents”
- Anne Kathleen Radcliff · Cubrc, Inc.$23,664,331
- Yat Sun Or · Enanta Pharmaceuticals, Inc.$23,534,108
- Bruce Blough · Research Triangle Institute$19,637,160
- Ramnik J Xavier · Broad Institute, Inc.$19,590,431
- David S Perlin · Hackensack University Medical Center$14,378,517
- Charles Testa · Echelon Biosciences, Inc.$13,103,850
Research focus
Anti-Bacterial AgentsComplexDna-Directed Rna PolymeraseBacterial RnaStructureGenetic TranscriptionDesignTranscription InitiationGrowthBinding SitesRifampinSingle MoleculeTranscription ElongationResistanceBacterial InfectionsExhibitsAffectProteinsGene ExpressionKineticsReactionPharmaceutical PreparationsEscherichia ColiInhibitor/Antagonist
Grant awards (64)
Therapeutics for drug-resistant bacteria: arylmyxopyronins$944,067
U19 · FY2025 · AI · contact PI
Prokaryotic Transcription Termination R37GM041376-R01GM041376 - Competitive Renewal Resubmission 1$535,760
R01 · FY2025 · GM · contact PI
Prokaryotic Transcription Termination R37GM041376-R01GM041376 - Competitive Renewal Resubmission 1$535,047
R01 · FY2024 · GM · contact PI
Prokaryotic Transcription Termination, Administrative Supplement$223,865
R01 · FY2024 · GM · contact PI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols$651,550
U19 · FY2023 · AI · contact PI
Prokaryotic Transcription Termination R37GM041376-R01GM041376 - Competitive Renewal Resubmission 1$534,373
R01 · FY2023 · GM · contact PI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols$651,550
U19 · FY2022 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$515,171
R37 · FY2022 · GM · contact PI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols$644,839
U19 · FY2021 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$515,171
R37 · FY2021 · GM · contact PI
Bacterial Transcription Complexes$51,000
R37 · FY2021 · GM · contact PI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols$642,434
U19 · FY2020 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$515,171
R37 · FY2020 · GM · contact PI
Bacterial Transcription Complexes$91,141
R37 · FY2020 · GM · contact PI
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols$662,525
U19 · FY2019 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$515,171
R37 · FY2019 · GM · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$515,171
R37 · FY2018 · GM · contact PI
Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinols$287,370
U19 · FY2018 · AI · contact PI
Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinols$161,193
U19 · FY2018 · AI · contact PI
Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins$1,021,724
R01 · FY2017 · AI · contact PI
Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinols$702,308
U19 · FY2017 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$449,399
R37 · FY2017 · GM · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$41,337
R37 · FY2017 · GM · contact PI
Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins$1,021,724
R01 · FY2016 · AI · contact PI
Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinols$470,040
U19 · FY2016 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$449,399
R37 · FY2016 · GM · contact PI
Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins$1,021,724
R01 · FY2015 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$450,943
R37 · FY2015 · GM · contact PI
Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinols$449,075
U19 · FY2015 · AI · contact PI
Therapeutics for Drug-Resistant Bacteria: Myxopyronins$1,212,985
R01 · FY2014 · AI · contact PI
Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins$1,021,724
R01 · FY2014 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$452,255
R37 · FY2014 · GM · contact PI
Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinols$444,069
U19 · FY2014 · AI · contact PI
Therapeutics for Drug-Resistant Bacteria: Myxopyronins$1,140,206
R01 · FY2013 · AI · contact PI
Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins$1,048,947
R01 · FY2013 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$452,255
R37 · FY2013 · GM · contact PI
Therapeutics for Drug-Resistant Bacteria: Myxopyronins$1,212,985
R01 · FY2012 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$374,706
R01 · FY2012 · GM · contact PI
Therapeutics for Drug-Resistant Bacteria: Myxopyronins$1,209,380
R01 · FY2011 · AI · contact PI
INHIBITORS OF BACTERIAL RNA POLYMERASE: "SWITCH REGION"$559,639
R01 · FY2011 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$374,706
R01 · FY2011 · GM · contact PI
Therapeutics for Drug-Resistant Bacteria: Myxopyronins$1,248,037
R01 · FY2010 · AI · contact PI
INHIBITORS OF BACTERIAL RNA POLYMERASE: "SWITCH REGION"$582,230
R01 · FY2010 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$378,588
R01 · FY2010 · GM · contact PI
INHIBITORS OF BACTERIAL RNA POLYMERASE: "SWITCH REGION"$588,112
R01 · FY2009 · AI · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$371,380
R01 · FY2009 · GM · contact PI
BACTERIAL TRANSCRIPTION COMPLEXES$48,358
R01 · FY2009 · GM · contact PI
INHIBITORS OF BACTERIAL RNA POLYMERASE: "SWITCH REGION"$588,112
R01 · FY2008 · AI · contact PI
Bacterial Transcription Complexes$302,720
R01 · FY2008 · GM · contact PI
INHIBITORS OF BACTERIAL RNA POLYMERASE: "SWITCH REGION"$598,532
R01 · FY2007 · AI · contact PI
Bacterial Transcription Complexes$302,118
R01 · FY2007 · GM · contact PI
Bacterial Transcription Complexes$301,674
R01 · FY2006 · GM · contact PI
Bacterial Transcription Complexes$301,621
R01 · FY2005 · GM
BACTERIAL TRANSCRIPTION COMPLEXES$263,689
R01 · FY2004 · GM
BACTERIAL TRANSCRIPTION COMPLEXES$263,689
R01 · FY2003 · GM
EUKARYOTIC TRANSCRIPTION COMPLEXES$172,926
R01 · FY2003 · GM
BACTERIAL TRANSCRIPTION COMPLEXES$263,689
R01 · FY2002 · GM
EUKARYOTIC TRANSCRIPTION COMPLEXES$167,981
R01 · FY2002 · GM
MODELS OF REGULATORY NETWORKS$0
P20 · FY2002 · GM
BACTERIAL TRANSCRIPTION COMPLEXES$263,689
R01 · FY2001 · GM
EUKARYOTIC TRANSCRIPTION COMPLEXES$163,180
R01 · FY2001 · GM
MODELS OF REGULATORY NETWORKS$0
P20 · FY2001 · GM
BACTERIAL TRANSCRIPTION COMPLEXES$274,225
R01 · FY2000 · GM
EUKARYOTIC TRANSCRIPTION COMPLEXES$158,519
R01 · FY2000 · GM